Zibo Qianhui Biological Technology Co., Ltd

Founded in 2006 and located in Polymer industrial park of Zibo High-tech District, Zibo Qianhui Biological Technology Co., Ltd is a high-tech enterprise specialized in the fields of research, manufacturing and trade.

Qianhui is professional in manufacturing cyclodextrin and its derivatives which could be used as pharmacutical excipients, food & cosmetic additives etc.

Developed new type injectable excipient Betadex Sulfobutyl Ether Sodium independently and filled the gap in domestic market, our Betadex Sulfobutyl Ether Sodium is the first one to pass the technical evaluation with related preparations (Registration status "A"). USA FDA DMF No.: 29394, the first and only on to get CEP certificate: No. R0-CEP 2021-025-Rev 00, CDE registration No.: F20180000620.

Hydroxypropyl Beta Cyclodextrin has been widely used and approved by global markets. USA FDA DMF No.: 033403, CDE registration No.: F20209990335 (Oral, Registration status is "A") / F20180000146 (Oral) / F20180000895 (Injection).

Hydroxypropyl Gamma Cyclodextrin USA FDA DMF No.: 037123, CDE registration No.: F20210000388.

Methyl Beta Cyclodextrin USA FDA DMF No.: 039021, CDE registration No.: F20230000427.

Gamma Cyclodextrin CDE registration No.: F20210000589.

Insisting on innovation-driven development strategy, keeping market demand as central task, keeping doing finer and more professional, Qianhui has launched series of cyclodextrin derivatives, such as Hydroxypropyl Beta Cyclodextrin, Betadex Sulfobutyl Ether Sodium, Methyl Beta Cyclodextrin, Gamma Cyclodextrin, Hydroxypropyl Gamma Cyclodextrin and so on. Paralleling innovation and development, Qianhui also attaches importance to the protection of intellectual property rights. 10 invention patents and 39 utility model patents have been authorized until now.

Science and Technological innovation promotes rapid development of the company. Qianhui has been granted as National little giant enterprise, Shandong manufacturing single champion enterprise, Shandong specialization, refinement, specificity and novelty SMEs, Shandong gazelle enterprise. Activing in Industry-University-Research cooperation, Qianhui has co-established China cyclodextrin application and research center with China Pharmaceutical University, and National Key Food Lab of Zibo Cyclodextrin Center with Jiangnan University, and be the Shandong "One Enterprise, One Technology" Research Center successfully.

Since 2017 to 2020, Qianhui had undertaken the sub-project of Shandong Province self-created area, sub-project of the national science and technology major special project of new drug creation and development, projects of Double Ten science and technology plan of Zibo City, key special project of MOST "Science and Technology Boosts Economy 2020" etc.

Owning scientific and complete product structure, Qianhui has formed natural α , β , γ Cyclodextrin and its derivatives serialization cyclodextrin products. All of the products have been widely used in various fields. With the excellent product quality and the management philosophy of "Be grateful to customers, thinking what customers think, meeting what customers demand", we set up Qianhui brand in pharmaceutials, food & cosmetics fields. Served more than 60 countries and 2500 clients, our products have been exported to Europe, North America, South America, Central and South Asia, Middle East and other regions successfully.

Based on the devoting of product development, keeping researching compounding technology, providing comprehensive cyclodextrin application technology solutions, we are satisfying customers and helping them to achieve the maximum value with excellent products and complete service.

"Stand century-old Qianhui, Do the best excipients" is the eternal mission of Qianhui people